TY - JOUR
KW - Physicians
KW - Collaboration
KW - Buprenorphine -- Therapeutic Use
KW - Pharmacists
KW - Interprofessional Relations
KW - Analgesics, Opioid
KW - substance use disorders
KW - Models, Theoretical
KW - buprenorphine
KW - Nonrandomized Trials
KW - United States
KW - Pharmacy, Retail
KW - Treatment Outcomes
KW - Drug Monitoring
KW - Patient Safety
KW - Patient Satisfaction
KW - Human
AU - Li‐Tzy Wu
AU - William S. John
AU - Udi E. Ghitza
AU - Aimee Wahle
AU - Abigail G. Matthews
AU - Mitra Lewis
AU - Brett Hart
AU - Zach Hubbard
AU - Lynn A. Bowlby
AU - Lawrence H. Greenblatt
AU - Paolo Mannelli
A1 - 
AD - Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham NC,, USA; Department of Medicine, Division of General Internal Medicine, Duke University School of Medicine, Durham NC,, USA; Duke Clinical Research Institute, Duke University School of Medicine, Durham NC,, USA; Center for Child and Family Policy, Sanford School of Public Policy, Duke University, Durham NC,, USA; Duke Institute For Brain Sciences, Duke University, Durham NC,, USA; National Institute on Drug Abuse, Bethesda MD,, USA; The Emmes Company, LLC, Rockville MD,, USA
BT - Addiction
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 7
CY - Malden, Massachusetts
DO - 10.1111/add.15353
IS - 7
JF - Addiction
LA - English
M1 - Journal Article
PB - Wiley-Blackwell
PP - Malden, Massachusetts
PY - 2021
SN - 0965-2140
SP - 1805
EP - 1816
EP - 
T1 - Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network
T2 - Addiction
TI - Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1111/add.15353
VL - 116
VO - 0965-2140
Y1 - 2021
Y2 - 07
ER -